Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Momenta Pharma (MNTA)

Momenta Pharma (MNTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,535,192
  • Shares Outstanding, K 98,917
  • Annual Sales, $ 75,590 K
  • Annual Income, $ -176,060 K
  • 60-Month Beta 2.07
  • Price/Sales 20.15
  • Price/Cash Flow N/A
  • Price/Book 5.58

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.59
  • Number of Estimates 5
  • High Estimate -0.47
  • Low Estimate -0.81
  • Prior Year -0.07
  • Growth Rate Est. (year over year) -742.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.14 +9.76%
on 10/22/19
16.90 -8.17%
on 11/12/19
+1.15 (+8.00%)
since 10/21/19
3-Month
11.91 +30.31%
on 08/23/19
16.90 -8.17%
on 11/12/19
+3.21 (+26.08%)
since 08/21/19
52-Week
9.51 +63.20%
on 07/22/19
16.90 -8.17%
on 11/12/19
+2.96 (+23.57%)
since 11/21/18

Most Recent Stories

More News
Momenta Pharmaceuticals Announces Poster Presentation at the 61st American Society of Hematology Annual Meeting and Exposition

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) today announced that Santiago Arroyo, M.D., Ph.D., Chief Medical Officer, will deliver a poster presentation at the upcoming 61 American Society of Hematology...

MNTA : 15.52 (+0.78%)
Myriad Genetics has the Best Relative Performance in the Biotechnology Industry (MYGN , MNTA , BPMC , ICPT , TGTX )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

BPMC : 76.97 (+1.69%)
MNTA : 15.52 (+0.78%)
MYGN : 25.11 (+0.44%)
Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced that it will...

MNTA : 15.52 (+0.78%)
Momenta Pharmaceuticals (MNTA) Reports Q3 Loss, Tops Revenue Estimates

Momenta (MNTA) delivered earnings and revenue surprises of -14.29% and 39.06%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

MNTA : 15.52 (+0.78%)
Momenta: 3Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Momenta Pharmaceuticals Inc. (MNTA) on Thursday reported a loss of $44.5 million in its third quarter.

MNTA : 15.52 (+0.78%)
Momenta Pharmaceuticals Reports Third Quarter 2019 Financial and Operating Results

Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today reported its financial...

MNTA : 15.52 (+0.78%)
Hospitals, Third-Party Payors, and People Who Bought or Provided Reimbursement for the Anticoagulant Medications Lovenox® or Generic Enoxaparin, Could Be Included in a Class Action Lawsuit

The following is being released by Lieff Cabraser Heimann & Bernstein, LLP.

MNTA : 15.52 (+0.78%)
Momenta Pharmaceuticals Announces Date of Third Quarter 2019 Financial Results Conference Call and Webcast

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced that it will...

MNTA : 15.52 (+0.78%)
Momenta Pharmace Shares Up 20.6% Since SmarTrend's Buy Recommendation (MNTA)

SmarTrend identified an Uptrend for Momenta Pharmace (NASDAQ:MNTA) on July 31st, 2019 at $11.41. In approximately 2 months, Momenta Pharmace has returned 20.60% as of today's recent price of $13.76.

MNTA : 15.52 (+0.78%)
Spectrum Pharmac is Among the Companies in the Biotechnology Industry with the Best Relative Performance (SPPI , VNDA , MNTA , ESPR , CHRS )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

MNTA : 15.52 (+0.78%)
SPPI : 8.65 (-0.46%)
VNDA : 15.67 (+0.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

The current trending strength of the market is Good.

See More Share

Trade MNTA with:

Business Summary

Momenta Pharmaceuticals is a leader in the analysis, characterization and design of complex pharmaceutical products. Their scientific foundation is a set of tools and methods that allow them to develop a deep understanding of the links between a compound's chemical structure, biological function and...

See More

Key Turning Points

2nd Resistance Point 15.99
1st Resistance Point 15.76
Last Price 15.52
1st Support Level 15.24
2nd Support Level 14.95

See More

52-Week High 16.90
Last Price 15.52
Fibonacci 61.8% 14.08
Fibonacci 50% 13.20
Fibonacci 38.2% 12.33
52-Week Low 9.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar